All In Biotech

Drug Trial Radar · NCT01572909

Evaluation of Myocardial Effects of MTP-131 for Reducing Reperfusion Injury in Patients With Acute Coronary Events

A Phase 2a Trial to Evaluate the Safety, Tolerability and Efficacy of Intravenous MTP-131 on Reperfusion Injury in Patients Undergoing Primary Percutaneous Coronary Intervention and Stenting for ST-segment Elevation Myocardial Infarction Infarction

Last checked: Nov 20, 2026Latest source record: Jun 11, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

300

Actual

Start

Apr 2012

Primary completion

Nov 2014

Study completion Feb 2015

Sponsor

Lead sponsor
Stealth BioTherapeutics Inc.Industry
Sponsor type
Industry
Collaborators
ICON Clinical Research
First posted
Apr 6, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The EMBRACE-STEMI trial was a Phase 2a prospective, multicenter, multinational randomized, double-blind, placebo-controlled study designed to assess the safety, tolerability, and efficacy of IV administered elamipretide (also known as MTP-131, or Bendavia) on a background of standard-of-care therapy for reduction of reperfusion injury in patients with first time acute, anterior wall ST-segment elevation myocardial infarction (STEMI).

Conditions

  • Reperfusion Injury
  • STEMI

Interventions

  • Bendavia (MTP-131)Drug

    0.05 mg/kg/hr

  • PlaceboDrug

    Identically appearing placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Area Under the Curve (AUC) of Serum Creatine Kinase Isoenzyme Type Muscle-brain (CK-MB)Time frame: The initial 24 and 72 hours post-percutaneous coronary intervention (PCI)

Locations

30 sites in 4 countries. Site status is shown where the registry gives one.

  • Advanced Medical Research Center

    Port Orange, Florida

  • Henry Ford Hospital

    Detroit, Michigan

  • Creighton Cardiac Center

    Omaha, Nebraska

  • Universitätsmedizin Berlin, Charité Campus Benjamin Franklin

    Berlin, Germany

  • Staedtische Kliniken Bielefeld

    Bielefeld, Germany

  • Marienhaus Klinikum Eifel

    Bitburg, Germany

  • Universitaetsklinikum Freiburg

    Freiburg im Breisgau, Germany

  • Klinikum Herford

    Herford, Germany

  • Robert-Bosch-Krankenhaus Kardiologie

    Stuttgart, Germany

  • Helios Klinikum Wuppertal, Herzzentrum Elberfeld

    Wuppertal, Germany

  • Gottsegen Gyorgy Orszagos Kardiologiai Intezet

    Budapest, Hungary

  • Semmelweis Egyetem Kardiológiai Központ, Városmajor u. 68

    Budapest, Hungary

  • Honvédkórház-Állami Egészségügyi Központ

    Budapest, Hungary

  • PTE Klinikai Központ Szívgyógyászati Klinika

    Pécs, Hungary

  • Szent György Kórház, II. Belgyógyászati Osztály

    Székesfehérvár, Hungary

  • Zala Megyei Kórház, Kardiológiai Osztály, Zrínyi Miklós út 1.

    Zalaegerszeg, Hungary

  • Medical University of Bialystok

    Bialystok, Poland

  • SPSK Nr 7 Klaskiego Uniwersytetu Medycznego w Katowicach, Gornoslaskie Centrum Medyczne im. Prof. Leszka Gieca, III Oddzial Kardiologii, Zklad Kardiologii Inwazjnejul, Ziolowa 45-47

    Katowice, Poland

  • SPSK Nr 7 Slaskiego Uniwersytetu Medycznego w Katowicach, Gornoslaskie Centrum Medyczne im. Prof. Leszaka Gieca, I Oddzial Kardiologii, ul. Ziolowa 45-47

    Katowice, Poland

  • Wojewodzki Szpital Zespolony w Kielcach, Swietokrzyskie Centrum Kardiologii

    Kielce, Poland

  • Krakowski Szpital Specjalistyczny im. Jana Pwla II, Centrum Interwencyjnego Leczenia Chorob Serca i Naczyn z Pododdzialem Kariologii Interwencyjnej

    Krakow, Poland

  • Wojewodzki Specjalistyczny Szpital im WI. Bieganskiego, II Katedra i Klinika Kardiologii Uniwersytetu Medycznego w Lodzi, Pracownia Kardiologii Inwazyinej, ul. Kniaziewicza 1/5

    Lodz, Poland

  • SP ZOZ Wojewodzkie Centrum Medyczne, Zaklad Diagnostyki Obrazowej, AI. W. Witosa 26

    Opole, Poland

  • Centrum Kardiologii Inwazyjnej, Elektroterapii i Angiologii

    Oświęcim, Poland

  • Szpital Bielanski im. ks. Jerzego Popieluszki

    Warsaw, Poland

  • Samodzielny Publiczny Centralny Szpital Kliniczny w Warszawie, Pracownia Kardiologii Inwazyjnej

    Warsaw, Poland

  • Instytut Kardiologii im. Prymasa Tysiaclecia Stefana Kardynala Wyszynskiego

    Warsaw, Poland

  • Dolnoslaski Szpital Specjalistyczny im. T. Marciniaka, Centrum Medycyny Ratunkowe

    Wroclaw, Poland

  • Wojewodzki Szpital Specjalistyczny we Wroclawiu, Oddzial Kardiologiczny, ul. H. Kamieskiego 73a

    Wroclaw, Poland

  • Samodzielny Publiczny Szpital Wojewodzki im. Papieza Jana Pawla II w Zamosciu, Oddzial Kardiologii z Pododdzialem Intensywnej Terapil Kardiologicznej, ul. Aleje Jana Pawta II 10

    Zamość, Poland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.